These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20883027)

  • 1. A new fluorogenic peptide determines proteasome activity in single cells.
    Urru SA; Veglianese P; De Luigi A; Fumagalli E; Erba E; Gonella Diaza R; Carrà A; Davoli E; Borsello T; Forloni G; Pengo N; Monzani E; Cascio P; Cenci S; Sitia R; Salmona M
    J Med Chem; 2010 Oct; 53(20):7452-60. PubMed ID: 20883027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling proteasome activity in tissue with fluorescent probes.
    Berkers CR; van Leeuwen FW; Groothuis TA; Peperzak V; van Tilburg EW; Borst J; Neefjes JJ; Ovaa H
    Mol Pharm; 2007; 4(5):739-48. PubMed ID: 17708652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid peptide attenuates the proteasome activity in neuronal cells.
    Oh S; Hong HS; Hwang E; Sim HJ; Lee W; Shin SJ; Mook-Jung I
    Mech Ageing Dev; 2005 Dec; 126(12):1292-9. PubMed ID: 16153690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-based proteasome activity profiling.
    de Jong A; Schuurman KG; Rodenko B; Ovaa H; Berkers CR
    Methods Mol Biol; 2012; 803():183-204. PubMed ID: 22065226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.
    Xu B; Monsarrat B; Gairin JE; Girbal-Neuhauser E
    Fundam Clin Pharmacol; 2004 Apr; 18(2):171-80. PubMed ID: 15066131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo.
    Verdoes M; Florea BI; Menendez-Benito V; Maynard CJ; Witte MD; van der Linden WA; van den Nieuwendijk AM; Hofmann T; Berkers CR; van Leeuwen FW; Groothuis TA; Leeuwenburgh MA; Ovaa H; Neefjes JJ; Filippov DV; van der Marel GA; Dantuma NP; Overkleeft HS
    Chem Biol; 2006 Nov; 13(11):1217-26. PubMed ID: 17114003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin, chrysin, and luteolin selectively inhibit chymotrypsin-like and trypsin-like proteasome catalytic activities in tumor cells.
    Wu YX; Fang X
    Planta Med; 2010 Feb; 76(2):128-32. PubMed ID: 19653143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.
    Bett JS; Goellner GM; Woodman B; Pratt G; Rechsteiner M; Bates GP
    Hum Mol Genet; 2006 Jan; 15(1):33-44. PubMed ID: 16311253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
    Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
    Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
    Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
    Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary studies of new proteasome inhibitors in the tumor targeting approach: synthesis and in vitro cytotoxicity.
    Vivier M; Jarrousse AS; Bouchon B; Galmier MJ; Auzeloux P; Sauzieres J; Madelmont JC
    J Med Chem; 2005 Oct; 48(21):6731-40. PubMed ID: 16220988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the distribution and dynamics of proteasomes in living cells.
    Groothuis TA; Reits EA
    Methods Enzymol; 2005; 399():549-63. PubMed ID: 16338381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
    Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
    J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
    Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
    Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent reporters for the ubiquitin-proteasome system.
    Salomons FA; Verhoef LG; Dantuma NP
    Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities.
    Kloss A; Henklein P; Siele D; Schmolke M; Apcher S; Kuehn L; Sheppard PW; Dahlmann B
    Eur J Pharm Biopharm; 2009 May; 72(1):219-25. PubMed ID: 19027853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application and analysis of the GFPu family of ubiquitin-proteasome system reporters.
    Bence NF; Bennett EJ; Kopito RR
    Methods Enzymol; 2005; 399():481-90. PubMed ID: 16338377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
    Liu Z; Miers WR; Wei L; Barrett EJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of cerebral cortex and hippocampal proteasome subunit expression and function in a traumatic brain injury rat model.
    Yao X; Liu J; McCabe JT
    J Neurochem; 2008 Jan; 104(2):353-63. PubMed ID: 17944870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.